FNY Fact Sheet: First Trust Mid Cap Growth AlphaDEX Fund
Share
$95.20
close, Nov 18, 2026
Over the year to Nov 18, 2026, FNY returned +9.7% in total and charged 0.73% a year.
- 1-year total return
- +9.7%
- IWV +12.0% to Nov 18, 2026
- Expense ratio
- 0.73%
- a year
- Net assets
- $529m
- on Nov 17, 2026
- Net flow, last 5 trading days
- $0
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
FNY $10,966 +9.7% · IWV $11,199 +12.0% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−1.5%
3 months−9.9%
Year to date+4.4%
1 year+9.7%
3 years+58.2%
5 years+24.2%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Glaukos Corporation1.14%
Chime Financial, Inc. (Class A)0.96%
Concentra Group Holdings Parent, Inc.0.95%
Exelixis, Inc.0.91%
Hinge Health, Inc. (Class A)0.91%
LifeStance Health Group, Inc.0.91%
PACS Group, Inc.0.90%
Haemonetics Corporation0.89%
Charles River Laboratories International, Inc.0.87%
TG Therapeutics, Inc.0.87%
FNY top ten by weight, 9.3% of the fund, of its 225 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the Nasdaq AlphaDEX Mid Cap Growth Index · First traded Apr 20, 2011 · Benchmark Russell 3000 Index, measured by IWV, which tracks the same index